Trospium Chloride Tablet, Film Coated
Product Images NDC 70518-4593

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Trospium Chloride (NDC 70518-4593). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

This text provides information about Trospium Chloride Tablet, its dosage, storage instructions, and details such as the NDC number, lot number, expiration date, and the tablet's appearance. It also mentions that the tablet is repackaged by RemedyRepack.*

FDA Label Image

Mm1 (Trospium Chloride 20mg 70518 4593 00)

This text provides information on Trospium Chloride Tablets, including the dosage instructions, storage conditions, quantity per box, NDC number, and repackaging details by RemedyRepack Inc. It also mentions the address and contact information for RemedyRepack in Indiana, PA.*

FDA Label Image

Structure (Bf13cc11 83d9 43c1 9604 005aaba70123 01)

FDA Label Image

Figure 1 (Bf13cc11 83d9 43c1 9604 005aaba70123 02)

This text provides information on plasma concentration (ng/mL) over time (hours post-dose). It includes a table displaying plasma concentrations at specific time points.*

FDA Label Image

Figure 2 (Bf13cc11 83d9 43c1 9604 005aaba70123 03)

This is a data table showing the mean change in measurements between a placebo group of 256 and a group treated with trospium chloride of 253 participants. The statistical significance level is denoted as p<0.001, and the evaluation was conducted over a 12-week treatment period.*

FDA Label Image

Figure 3 (Bf13cc11 83d9 43c1 9604 005aaba70123 04)

This text provides information on the mean change in a study comparing the effects of placebo versus trospium chloride treatment over a certain period. The mean change was significant with a p-value of 0.012 after a specified number of weeks of treatment.*

FDA Label Image

Figure 4 (Bf13cc11 83d9 43c1 9604 005aaba70123 05)

This text provides information on the mean change in a study comparing a placebo group (N=325) with a group receiving trospium chloride (N=323) after a certain number of weeks of treatment. The statistical significance of the results is indicated as p<0.001. The specific details of the study and the treatment being evaluated are not available in this extracted text.*

FDA Label Image

Figure 5 (Bf13cc11 83d9 43c1 9604 005aaba70123 06)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.